Time to give up and move on...
I hope all the miserable Ecopia shareholders will dump massively their shares in the coming days.
Thallion has now 0,50$ per share of cash.
Shigamabs to look forward:
No regulatory risk (accelerated approval FDA, orphan drug status for EMEA and FDA)
All expense paid for by French Group
Added bonus - 232 binding arbitration ruling - coming up
232 has already demonstrated 33% efficacy in PII trials.
Safe and tolerable.
New potent dosage to be explore.
Only M2PK compound in clinical trial.
Now - market will correct at some point and reprice the stock at proper level.
I expect we trade near 0,50$.
Now, please sell.
In 4 to 5 weeks, deal will be formalized with French group as regulatory approval is obtained.